Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers

• Jordi Heijman,
• Ann-Kathrin Rahm,
• Dobromir Dobrev

Affiliations

Jordi Heijman

Corresponding author at: Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.; Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine, and Life Sciences, Maastricht University and Maastricht UMC+, Maastricht, the Netherlands

Ann-Kathrin Rahm

Department of Cardiology and Heidelberg Center for Heart Rhythm Disorders (HCR), University Hospital Heidelberg and German Centre for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany

Dobromir Dobrev

Institute of Pharmacology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany; Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX, United States; Departments of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Canada